Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Osteoporos Int ; 30(5): 1025-1031, 2019 May.
Article in English | MEDLINE | ID: mdl-30701344

ABSTRACT

Mortality and remaining bedridden following the hip fracture surgery are not rare. We tried to measure the levels of inflammatory markers tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) following the hip fracture surgery and compare their levels with controls. We aimed to show a relationship between the levels of these markers and post-operative mortality and walking capability. INTRODUCTION: Osteoporosis is a condition, causing the hip fractures in the elderly. Hip fractures have a high rate of overall mortality up to 30% following the incident. Cytokines such as IL-6 and TNF-α are suggested to play a role in bone resorption and, thus, in the etiology of osteoporosis. METHODS: Plasma levels of IL-6 and TNF-α were measured pre-operatively and on the first and second days after the surgery in 40 Turkish hip fracture patients. The levels of these cytokines were compared with 40 Turkish age-matched healthy controls. The levels of these cytokines were compared between the deceased and surviving patients, as well as the existence of walking capability following the surgery. RESULTS: Significantly higher IL-6 levels were shown on the first and second days after the surgery (p = 0.005; p = 0.01, respectively). The overall death rate of our study group within the 2-year follow-up time was found to be 35%. No statistical significance was found in the means of 2-year follow-up mortality between the patients. Presence of walking capability did not differ between the patients, as well. CONCLUSION: We demonstrated an association between IL-6 levels and hip fracture in our study group following the surgery. We also suggest that TNF-α and IL-6 levels are not related to the occurrence of death and walking capability after the surgery. However, these findings need further functional and clinical confirmation.


Subject(s)
Hip Fractures/immunology , Inflammation Mediators/metabolism , Interleukin-6/blood , Osteoporotic Fractures/immunology , Tumor Necrosis Factor-alpha/blood , Aged , Biomarkers/blood , Case-Control Studies , Female , Follow-Up Studies , Hip Fractures/mortality , Hip Fractures/surgery , Humans , Male , Middle Aged , Osteoporotic Fractures/mortality , Osteoporotic Fractures/surgery , Postoperative Period , Preoperative Period , Prognosis , Turkey/epidemiology , Walking
SELECTION OF CITATIONS
SEARCH DETAIL
...